Human Metapneumovirus (hMPV)
This assay is only available as part of a panel and cannot be ordered individually.
Human Metapneumovirus (hMPV) was first discovered in 2001; poor growth in cell culture is the main factor for the virus' delayed discovery. hMPV is distributed worldwide and is a major cause of respiratory tract illness, particularly in young children and immunocompromised patients. The clinical manifestations of hMPV infections are similar to respiratory syncytial virus (RSV) and range from mild upper-airway disease to severe pneumonia and respiratory failure.
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Eurofins Viracor's interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.